American Century Companies’s Cullinan Oncology CGEM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $943K | Buy |
125,189
+12,519
| +11% | +$94.3K | ﹤0.01% | 2314 |
|
|
2025
Q1 | $853K | Buy |
112,670
+11,949
| +12% | +$90.5K | ﹤0.01% | 2303 |
|
|
2024
Q4 | $1.23M | Buy |
100,721
+10,010
| +11% | +$122K | ﹤0.01% | 2194 |
|
|
2024
Q3 | $1.52M | Buy |
90,711
+14,693
| +19% | +$246K | ﹤0.01% | 2073 |
|
|
2024
Q2 | $1.33M | Buy |
76,018
+18,840
| +33% | +$329K | ﹤0.01% | 2062 |
|
|
2024
Q1 | $974K | Buy |
57,178
+15,725
| +38% | +$268K | ﹤0.01% | 2161 |
|
|
2023
Q4 | $422K | Sell |
41,453
-251,400
| -86% | -$2.56M | ﹤0.01% | 2434 |
|
|
2023
Q3 | $2.65M | Sell |
292,853
-17,660
| -6% | -$160K | ﹤0.01% | 1583 |
|
|
2023
Q2 | $3.34M | Sell |
310,513
-12,415
| -4% | -$134K | ﹤0.01% | 1457 |
|
|
2023
Q1 | $3.29M | Buy |
322,928
+56,655
| +21% | +$578K | ﹤0.01% | 1418 |
|
|
2022
Q4 | $2.81M | Buy |
266,273
+187,249
| +237% | +$1.98M | ﹤0.01% | 1452 |
|
|
2022
Q3 | $1.01M | Buy |
+79,024
| New | +$1.01M | ﹤0.01% | 1685 |
|